Stock Updates

Morning Trending Tickers: Regeneron Pharmaceuticals, Inc. (REGN)

Today’s top gainers include the company Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) which is in the industry Biotechnology, gaining 0.67% today. In the last week its performance is -1.07%, and 19.87% for the past quarter. Currently, Regeneron Pharmaceuticals, Inc., REGN has a target price of 441.05, so today’s gain of 0.67% is a significant step towards its target price. The GAP today is therefore 0.35%.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), has a market cap of 50.28 B, and is based in USA. Insider ownership is at 1.30%, and institutional ownership is 71.40%.

At the current price of 476.84, it has a dividend yield of *TBA, and its target price is 441.05. This is with a profit margin of 19.30%, and total debt/equity of 0.15. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has a P/E of 57.37, as well as a forward P/E of 31.12.

With a current EPS of 8.31, and a forecasted EPS growth for next year at 20.99%,Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has had a EPS growth for the past five years at 38.80%. For the next five years EPS growth is projected to be 19.13%.

Performance for the year is 30.11%. Since its IPO date on 04/02/1991, the total performance to date is 29.90%.

Volume today for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), is 662457, while its average volume is 955.55. Whilst the total gain today was 0.67%, it did have a day high of -2.49%.

Volatility for this week has been at 2.16%, and 2.33% for the month. The 52-week low for Regeneron Pharmaceuticals, Inc., REGN has been 46.56%, while the 52-week-high has reached -2.49%.

Looking at its return of investments, which is 18.20%, and its return on assets is 13.80%. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has an operating margin of 28.80%. With a sales growth of 9.80% quarter over quarter. Bearing in mind that Regeneron Pharmaceuticals, Inc., REGN is in the sector Healthcare, its long-term debt/equity is 0.14, and has a current ratio of 2.8 and 2.6 for quick ratio.

So what is the value of Regeneron Pharmaceuticals, Inc.? Well its PEG is 3, and the P/S is 10.1, along with a P/B of 10.35. Meanwhile it has a p/cash of 38.47.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment